Form 4: US Physical Therapy: Director Swanson Acquires Shares

Regg E. Swanson, a Director at US Physical Therapy Inc., has acquired 2,306 shares of common stock.

Summary

• Regg E. Swanson, a Director of U.S. Physical Therapy Inc. (USPH), acquired 2,306 shares of common stock on May 19, 2026.
• The acquisition was made at a price of $61.61 per share.
• Following this transaction, Swanson directly beneficially owns 15,492 shares.
• An additional 7,596 shares are held indirectly through the Regg E. Swanson Revocable Trust, where he serves as beneficiary and trustee.
• The 2,306 acquired shares were granted as restricted stock under the Company's Amended and Restated 2003 Stock Incentive Plan.
• Vesting for these restricted shares is staggered, with portions vesting on August 20, 2026 (1,153 shares), November 20, 2026 (576 shares), and March 6, 2027 (577 shares), contingent on his continued directorship.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it reflects an insider's commitment to the company through stock acquisition and a long-term incentive plan, but lacks broader financial or strategic information.

Positives

• Director acquisition of company stock can signal confidence in the company's future prospects.
• The restricted stock grant indicates a long-term incentive for the director to remain with the company and contribute to its success.
• The staggered vesting schedule aligns the director's interests with the company's performance over an extended period.

Negatives

• The filing does not provide information on the company's financial performance or strategic updates, making it difficult to assess the broader implications of this transaction.
• The acquisition price of $61.61 per share is a factual detail without immediate context for whether it represents a favorable valuation.

Risks

• The vesting of restricted stock is contingent on the director remaining in that role, implying a potential risk of forfeiture if the director departs.
• The filing does not detail any specific risks associated with the company's operations or market position.

Future Outlook

The future outlook is not directly addressed in this filing, which focuses on a specific insider transaction. However, the staggered vesting of restricted stock implies a forward-looking incentive for the director to remain with the company until March 2027.

Management Comments

• The filing is a statement of changes in beneficial ownership and does not contain direct comments from management regarding the transaction itself.

Industry Context

StockSavvy.ai notes that insider stock acquisitions, particularly by directors, are common in the healthcare services sector, including physical therapy providers. Such transactions can be interpreted as a positive signal of management's belief in the company's stability and growth potential, especially when part of a long-term incentive plan.

Corporate Governance

Related Party Transactions

• The acquisition of restricted stock by Director Regg E. Swanson is a related party transaction, as he is an insider of the company.

Stakeholder Impact

• Shareholders: May view the director's stock acquisition positively, indicating confidence in the company's value.
• Employees: The restricted stock plan highlights a mechanism for incentivizing key personnel.
• Management: The transaction reinforces the alignment of management interests with shareholder interests.

Next Steps

• Monitoring the vesting of the restricted stock on August 20, 2026, November 20, 2026, and March 6, 2027.
• Observing any future filings by Regg E. Swanson regarding changes in his beneficial ownership.

Key Dates

Keywords

US Physical Therapy, USPH, Form 4, Insider Trading, Stock Acquisition, Director, Restricted Stock, Beneficial Ownership, SEC Filing, Securities Exchange Act